Featured Research

from universities, journals, and other organizations

Researchers Block Transmission Of Malaria In Animal Tests

Date:
June 12, 2008
Source:
University of Copenhagen
Summary:
By disrupting the potassium channel of the malaria parasite, a team of researchers has been able to prevent new malaria parasites from forming in mosquitoes and has thereby broken the cycle of infection during recent animal tests.

By disrupting the potassium channel of the malaria parasite, a team of researchers has been able to prevent the malaria parasites from forming in mosquitoes and has thereby broken the cycle of infection during recent animal tests.

By genetically altering the malaria parasite through gene knock-out technology, a research team consisting of scientists at the University of Copenhagen and John Hopkins University, Baltimore, has prevented the parasite from going through the normal stages of its life cycle and developing a cyst (egg-like structure or occyst), which spawns new infectious parasites." As it is exclusively the parasites from these oocysts that can infect new individuals, we were able to prevent the disease from being transmitted to the animals in our tests", explains Assistant Professor, Peter Ellekvist from the University of Copenhagen.

The intervention "disrupts" the parasites complex life cycle

The malaria parasite has an extremely complicated lifecycle, which starts with the fertilisation of the parasites male and female gametes and the formation of an oocyst, in the mosquito's stomach wall. The oocyst further develops into sporozoittes, which travel up the mosquito's salivary gland and from there are transmitted to people, when the mosquito secures its next blood meal. After residing for a short period in the liver cells, the parasites then infect the red blood cells, thereby wreaking havoc in the human body.

The malaria parasites are able to reproduce both through sexual reproduction when they inhabit a mosquito (and are transmitted to the host) and via asexual reproduction when they reside in the human body (replication in the host). For scientists to successfully counteract malaria, they must tackle both the transmission from person to person by the mosquitoes and the spread of the malaria parasites in the infected individual.

The potassium channels are important for all cells

All animal and plant cells contain so-called ion channels. These are small pores which allow ions to move in and out through an otherwise impermeable cell membrane. The potassium channels are a sub-type of ion channel, found in all cells. Though the function of the potassium channels vary, they play a crucial role in a variety of biological processes, e.g. influencing the ability of the nerves to send electrical signals and the heart muscle to contract rhythmically.

Assistant Professor Peter Ellekvist explains that his interest in malaria led to a research collaboration with Professor Dan Klærke, who studies potassium channels at the University of Copenhagen. In collaboration with Professor Nirbhay Kumar and other colleagues from the Malaria Research Institute at John Hopkins University in Baltimore, the two researchers were able to manipulate the parasite's genes so as to ensure that the potassium channel no longer functioned. To their surprise, however, this intervention did not, in the first instance, appear to have any effect on the parasites.

"The gene knock-out parasites essentially killed the mice in the animal tests just as quickly as the "natural" parasites, that had not undergone genetic manipulation," explains Peter Ellekvist. "However, we found that the only parasites that were unable to reproduce sexually, were those with non-functioning potassium channels."

The experiments had effectively disrupted the insect's ability to pass on the disease.

Further research required

The next step for the research team is to examine whether parasites with non-functioning potassium channels react differently to anti-malaria drugs. A success here would allow the researchers to break the second phase of the infection cycle and prevent the asexual reproduction of the malaria parasites that have already gained access to the human body. Blocking the potassium channels of parasites in the body could, for example, render them more susceptible to anti-malaria drugs. Further testing is also required to see whether the manipulation of the potassium channels may also affect the other stages of the parasites lifecycle, such as their development within the liver cells.

The findings have been published in the scientific journal Proceedings of the National Academy of Sciences, USA, (2008 105: 6398-6402).


Story Source:

The above story is based on materials provided by University of Copenhagen. Note: Materials may be edited for content and length.


Cite This Page:

University of Copenhagen. "Researchers Block Transmission Of Malaria In Animal Tests." ScienceDaily. ScienceDaily, 12 June 2008. <www.sciencedaily.com/releases/2008/06/080609171152.htm>.
University of Copenhagen. (2008, June 12). Researchers Block Transmission Of Malaria In Animal Tests. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/06/080609171152.htm
University of Copenhagen. "Researchers Block Transmission Of Malaria In Animal Tests." ScienceDaily. www.sciencedaily.com/releases/2008/06/080609171152.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins